Dec 24, 2024, 14:25
Portia Smallbone: HCT in patients with MF and splanchnic vein thrombosis
Portia Smallbone , Hematologist and Transplant Physician at MD Anderson Cancer Center, shared a post on X:
“Pleased to share our work recently published in American Journal of Hematology.
In patients with MF and splanchnic vein thrombosis, HCT is feasible and curative , although long term sequelae of portal HTN require ongoing management.”
Authors: Portia Smallbone et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 24, 2024, 14:25
Dec 24, 2024, 14:23
Dec 24, 2024, 14:04
Dec 24, 2024, 14:02
Dec 24, 2024, 13:29
Dec 24, 2024, 12:28
Dec 24, 2024, 12:16